Anti-vegf protein compositions and methods for producing the same
US-2022162289-A1 · May 26, 2022 · US
using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)}
using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)} · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K1/06 |
| Official title | using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)} |
| Display label | using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)} |
| Total patents | 157 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 25 |
| 2022 | 36 |
| 2023 | 27 |
| 2024 | 17 |
| 2025 | 18 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Method for producing peptide compound, protective group-forming reagent, and aromatic heterocyclic compound
US-2021380633-A1 · Dec 9, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021371501-A1 · Dec 2, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11186625-B2 · Nov 30, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11180540-B2 · Nov 23, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11174283-B2 · Nov 16, 2021 · US
Readily isolated bispecific antibodies with native immunoglobulin format
US-11168111-B2 · Nov 9, 2021 · US
Analogs of 3,5-dihydroxypentanoate for bone formation
US-2021322411-A1 · Oct 21, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021284684-A1 · Sep 16, 2021 · US
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
US-11104715-B2 · Aug 31, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11098112-B2 · Aug 24, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11098311-B2 · Aug 24, 2021 · US
Synthesis of liraglutide
US-11066439-B2 · Jul 20, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021214430-A1 · Jul 15, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021214733-A1 · Jul 15, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021206833-A1 · Jul 8, 2021 · US
Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
US-2021206832-A1 · Jul 8, 2021 · US
Anti-VEGF protein compositions and methods for producing the same
US-11053280-B2 · Jul 6, 2021 · US
Peptoid, and its preparation method and use
US-2021188908-A1 · Jun 24, 2021 · US
Anti-vegf protein compositions and methods for producing the same
US-2021171570-A1 · Jun 10, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K1/06?
- CPC C07K1/06 is the Cooperative Patent Classification code for “using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)}.”
- How many patents are filed under CPC C07K1/06 (using protecting groups or activating agents {(C07K1/003, C07K1/006 take precedence)})?
- Our database includes 157 publications tagged with this CPC code.
- Is patent activity under CPC C07K1/06 growing?
- Publication counts under this code: 17 in 2024 vs 18 in 2025 (latest complete years).